These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 6305753)
1. Potentiation of the chemotherapeutic effect of 5-fluorouracil by combination with guanosine 5'-monophosphate. Iigo M; Nakajima Y; Kuretani K; Hoshi A Gan; 1983 Apr; 74(2):291-8. PubMed ID: 6305753 [TBL] [Abstract][Full Text] [Related]
2. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias. Iigo M; Hoshi A Eur J Cancer Clin Oncol; 1984 Mar; 20(3):411-5. PubMed ID: 6323189 [TBL] [Abstract][Full Text] [Related]
3. Effect of pyrimidines, purines and their nucleosides on antitumor activity of 5-fluorouracil against L-1210 leukemia. Iigo M; Ando N; Hoshi A; Kuretani K J Pharmacobiodyn; 1982 Jul; 5(7):515-20. PubMed ID: 7131236 [TBL] [Abstract][Full Text] [Related]
4. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450 [TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of 5-fluorouracil in combination with some additives which stimulate the formation of antineoplastic 5-fluorouracil nucleotides. Tamemasa O; Tezuka M Gan; 1983 Apr; 74(2):285-90. PubMed ID: 6407888 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds. Iigo M; Miwa M; Ishitsuka H; Nitta K Cancer Chemother Pharmacol; 1987; 19(1):61-4. PubMed ID: 3028664 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors. Hoshi A; Iigo M; Nakamura A; Yoshida M; Kuretani K Gan; 1976 Oct; 67(5):725-31. PubMed ID: 1017587 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of antitumor activity of 5-fluorouracil by ribothymidine. Tezuka M; Chiba Y; Okada S; Tamemasa O J Pharmacobiodyn; 1986 Aug; 9(8):683-7. PubMed ID: 3783412 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites. Fujimoto S; Ogawa M; Hoshino A Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770 [TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models. Schmid FA; Sirotnak FM; Otter GM; DeGraw JI Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784 [TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors. Fujimoto S; Wang Y; Inoue K; Ogawa M Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854 [TBL] [Abstract][Full Text] [Related]
12. Potentiation by vitamin A of the action of anticancer agents against murine tumors. Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine in the adenocarcinoma 755 system by guanosine 5'-monophosphate. Iigo M; Yamaizumi Z; Nakajima Y; Nishimura S; Hoshi A Drugs Exp Clin Res; 1988; 14(4):257-63. PubMed ID: 2458897 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors. Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356 [TBL] [Abstract][Full Text] [Related]
15. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of 1-alkoxycarbonylalkylcarbamoyl-5-fluorouracil derivatives by oral administration. Iigo M; Hoshi A; Inomata M; Ando N; Kuretani K J Pharmacobiodyn; 1981 Mar; 4(3):203-10. PubMed ID: 7252769 [TBL] [Abstract][Full Text] [Related]
18. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor. Myers CE; Young RC; Chabner BA Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26. Chiuten DF; Muggia FM; Johnson RK Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512 [No Abstract] [Full Text] [Related]
20. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice. Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]